The latest Y Combinator-backed startup is targeting the $36 billion contraceptive market.
View More YourChoice Therapeutics is developing unisex, non-hormonal birth controlCategory: Cancer
‘Jeopardy!’ host Alex Trebek tells fans he has stage 4 pancreatic cancer
Alex Trebek announced that he has cancer, but he plans on continuing to work through treatment.
The iconic host of Jeopardy! revealed his stage 4 pancreatic cancer diagnosis in a video released on the show’s YouTube channel on Wednesday, explai…
A healthcare investment fund has become one of Israel’s largest with a $660 million close
One of Israel’s single largest venture capital funds is a new later stage vehicle focused on healthcare. The aMoon investment firm launched its second vehicle in April 2018 and it just announced its final close with $660 million in assets under management — making it one of the largest (if not the largest) firm in […]
View More A healthcare investment fund has become one of Israel’s largest with a $660 million closeJ&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robots
Johnson & Johnson’s robotic surgery and medical device division, Ethicon, is dropping $3.4 billion in cash to pick up Auris Health, a developer of robotic diagnostics and surgical devices initially focused on detecting and treating lung cancer. The healthcare giant said an additional $2.35 billion in payouts may be possible if Auris hits certain milestones. […]
View More J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robotsHealthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologies
Evan Nisselson Contributor Evan Nisselson is a partner at LDV Capital. More posts by this contributor Deep learning with synthetic data will democratize the tech industry The war over artificial intelligence will be won with visual data Visual assessment is critical to healthcare – whether that is a doctor peering down your throat as you […]
View More Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologiesLack of transparency in healthcare startups risks another Theranos implosion
Are more Theranos -style scandals looming for investors in healthcare startups? A team of researchers associated with the Meta Research Innovation Center at Stanford thinks so. They’ve published a paper warning investors in life sciences startups that a systemic lack of transparency exists in their portfolio companies — creating the possibility for more multi-billion dollar implosions and […]
View More Lack of transparency in healthcare startups risks another Theranos implosionDog cancer treatment startup raises $5 million from Andreessen Horowitz and others
One in every three dogs gets cancer, according to the National Canine Cancer Foundation. OneHealth, a startup that just raised a $5 million seed round led by Andreessen Horowitz’s Bio fund with participation from Lerer Hippeau and Y Combinator, aims to make it easier for humans to treat canine cancer, which is the number one disease killer […]
View More Dog cancer treatment startup raises $5 million from Andreessen Horowitz and othersJohnson & Johnson reportedly knew for decades about asbestos in baby powder products
/https%3A%2F%2Fblueprint-api-production.s3.amazonaws.com%2Fuploads%2Fstory%2Fthumbnail%2F88538%2F8cadff4f-8be7-46b4-a9a4-44cc5aa488a6.jpg)
A report from Reuters claims that Johnson & Johnson apparently knew that there were asbestos — or microscopic fibers that can cause cancer — in its baby powder products
Earlier this year, J&J were ordered by a judge to pay over $4 billion in damages to 22 women and their families. Read more…
More about Mashable Video, Cancer, Johnson Johnson, Pharmaceuticals, and Asbestos
View More Johnson & Johnson reportedly knew for decades about asbestos in baby powder productsCompanies tracking mutations in cancer cells can provide a key to unlocking better therapies
Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can create more targeted therapies. Earlier this month, research using technology developed by the startup Mission Bio helped identify cellular mutations in acute myeloid leukemia cancer cells that could […]
View More Companies tracking mutations in cancer cells can provide a key to unlocking better therapiesChina’s Infervision is helping 280 hospitals worldwide detect cancers from images
Until recently, humans have relied on the trained eyes of doctors to diagnose diseases from medical images. Beijing-based Infervision is among a handful of artificial intelligence startups around the world racing to improve medical imaging analysis through deep learning, the same technology that powers face recognition and autonomous driving. The startup, which has to date raised $70 […]
View More China’s Infervision is helping 280 hospitals worldwide detect cancers from imagesHospital in China denies links to world’s first gene-edited babies
News of the world’s first ever gene-edited human babies being born in China caused a huge stir on Monday after the MIT Technology Review and the Associated Press brought the project to light. People in and outside China rushed to question the ethical implications of the scientific breakthrough, reportedly the fruit of a Chinese researcher named He Jiankui from a university […]
View More Hospital in China denies links to world’s first gene-edited babiesEzra raises $4M to diagnose cancer with MRIs, not painful biopsies
1 in 41 men will die of prostate cancer. But sticking a needle through your rectum into your prostate to screen for cancer brings along a ton of bacteria and terrible side effects like pain, infection, urinary trouble, and even erectile dysfunction. It turns out you can detect cancer with Magnetic Resonance Imaging…it’s just prohibitively […]
View More Ezra raises $4M to diagnose cancer with MRIs, not painful biopsies